Related references
Note: Only part of the references are listed.A Randomized, Placebo-Controlled Trial of Pentoxifylline on Erythropoiesis-Stimulating Agent Hyporesponsiveness in Anemic Patients With CKD: The Handling Erythropoietin Resistance With Oxpentifylline (HERO) Trial
David W. Johnson et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2015)
Pentoxifylline in Heart Failure: A Meta-Analysis of Clinical Trials
Sebastien Champion et al.
CARDIOVASCULAR THERAPEUTICS (2014)
Pentoxifylline does not alter the concentration of hepcidin in chronic kidney disease patients undergoing hemodialysis
Sandra A. Antunes et al.
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS (2014)
Prevalence of Anemia in Chronic Kidney Disease in the United States
Melissa E. Stauffer et al.
PLOS ONE (2014)
Evaluation of the Effect of Pentoxifylline on Erythropoietin-resistant Anemia in Hemodialysis Patients
Amir-Hooshang Mohammadpour et al.
SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION (2014)
Pentoxifylline for the Treatment of Hemolytic Anemia in a Patient Who Developed Recurrent Gastrointestinal Bleeding While on Continuous-Flow Left Ventricular Assist Device Support
Douglas L. Jennings et al.
ASAIO JOURNAL (2013)
Anaemia management and mortality risk in chronic kidney disease
Walter H. Hoerl
NATURE REVIEWS NEPHROLOGY (2013)
Immune cell dysfunction and inflammation in end-stage renal disease
Michiel G. H. Betjes
NATURE REVIEWS NEPHROLOGY (2013)
Anti-Inflammatory and Anti-Oxidative Nutrition in Hypoalbuminemic Dialysis Patients (AIONID) study: results of the pilot-feasibility, double-blind, randomized, placebo-controlled trial
Manoch Rattanasompattikul et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2013)
Mechanisms of Anemia in CKD
Jodie L. Babitt et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Pentoxifylline decreases serum levels of tumor necrosis factor alpha, interleukin 6 and C-reactive protein in hemodialysis patients: results of a randomized double-blind, controlled clinical trial
Liliana Gonzalez-Espinoza et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Do pentoxifylline and ascorbic acid improve erythropoiesis stimulating agent resistance?
Mira Rho
SEMINARS IN DIALYSIS (2011)
Impact of Pentoxifylline and Vitamin E on Ribavirin-Induced Haemolytic Anaemia in Chronic Hepatitis C Patients: An Egyptian Survey
M. Assem et al.
INTERNATIONAL JOURNAL OF HEPATOLOGY (2011)
An Economic Evaluation of Erythropoiesis-Stimulating Agents in CKD
Fiona M. Clement et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2010)
Pentoxifylline improves haemoglobin and interleukin-6 levels in chronic kidney disease
Paolo Ferrari et al.
NEPHROLOGY (2010)
Erythropoietic Response and Outcomes in Kidney Disease and Type 2 Diabetes.
Scott D. Solomon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
IMMUNOMODULATORY PROPERTIES OF PENTOXIFYLLINE ARE MEDIATED VIA ADENOSINE-DEPENDENT PATHWAYS
Simone Kreth et al.
SHOCK (2010)
Effect of Pentoxifylline on GFR Decline in CKD: A Pilot, Double-Blind, Randomized, Placebo-Controlled Trial
Robert M. Perkins et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2009)
Emerging therapies for chronic kidney disease: what is their role?
Eswari Vilayur et al.
NATURE REVIEWS NEPHROLOGY (2009)
Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes
Lynda A. Szczech et al.
KIDNEY INTERNATIONAL (2008)
Pentoxifylline improves hemoglobin levels in patients with erythropoietin-resistant anemia in renal failure
A Cooper et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
The cost-effectiveness of maintaining higher hemoglobin targets with erythropoietin in hemodialysis patients
M Tonelli et al.
KIDNEY INTERNATIONAL (2003)
Increased expression of erythropoiesis inhibiting cytokines (IFN-γ, TNF-α, IL-10, and IL-13) by T cells in patients exhibiting a poor response to erythropoietin therapy
AC Cooper et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Share Paper
